[go: up one dir, main page]

AU2001270642A1 - Method for the treatment of glaucoma and ocular hypertension by administering nucleotides - Google Patents

Method for the treatment of glaucoma and ocular hypertension by administering nucleotides

Info

Publication number
AU2001270642A1
AU2001270642A1 AU2001270642A AU7064201A AU2001270642A1 AU 2001270642 A1 AU2001270642 A1 AU 2001270642A1 AU 2001270642 A AU2001270642 A AU 2001270642A AU 7064201 A AU7064201 A AU 7064201A AU 2001270642 A1 AU2001270642 A1 AU 2001270642A1
Authority
AU
Australia
Prior art keywords
glaucoma
treatment
ocular hypertension
nucleotides
administering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001270642A
Inventor
Asuncion Peral Cerda
Jesus Pintor Just
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidad Complutense de Madrid
Original Assignee
Universidad Complutense de Madrid
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad Complutense de Madrid filed Critical Universidad Complutense de Madrid
Publication of AU2001270642A1 publication Critical patent/AU2001270642A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2001270642A 2000-07-06 2001-07-06 Method for the treatment of glaucoma and ocular hypertension by administering nucleotides Abandoned AU2001270642A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES200001670 2000-07-06
ES200001670A ES2173027B2 (en) 2000-07-06 2000-07-06 USE OF NUCLEOTIDES IN THE TREATMENT OF GLAUCOMA AND OCULAR HYPERTENSION.
PCT/ES2001/000271 WO2002007737A1 (en) 2000-07-06 2001-07-06 Method for the treatment of glaucoma and ocular hypertension by administering nucleotides

Publications (1)

Publication Number Publication Date
AU2001270642A1 true AU2001270642A1 (en) 2002-02-05

Family

ID=8494145

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001270642A Abandoned AU2001270642A1 (en) 2000-07-06 2001-07-06 Method for the treatment of glaucoma and ocular hypertension by administering nucleotides

Country Status (3)

Country Link
AU (1) AU2001270642A1 (en)
ES (1) ES2173027B2 (en)
WO (1) WO2002007737A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7084128B2 (en) * 2002-01-18 2006-08-01 Inspire Pharmaceuticals, Inc. Method for reducing intraocular pressure
WO2011077435A1 (en) * 2009-12-22 2011-06-30 Bar-Ilan University Compositions and methods for reducing intraocular pressure

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ283658A (en) * 1994-04-04 1999-09-29 William R Freeman Compositions and treatment of increased intraocular pressure with phosphonyl-alkyloxy-pyrimidines/purines (nucleosides)
JP2002173427A (en) * 1998-09-01 2002-06-21 Yamasa Shoyu Co Ltd Medicine composition for treating eye disease

Also Published As

Publication number Publication date
ES2173027B2 (en) 2005-12-16
ES2173027A2 (en) 2002-10-01
WO2002007737B1 (en) 2002-07-18
WO2002007737A1 (en) 2002-01-31
ES2173027R (en) 2002-10-16

Similar Documents

Publication Publication Date Title
AU2003223224A1 (en) Compositions and methods for the treatment of glaucoma and ocular hypertension
AU3998400A (en) Methods of treating c1s-mediated diseases and conditions, and compounds and compositions therefor
AU1709699A (en) 13-oxa prostaglandins for the treatment of glaucoma and ocular hypertension
AU2002307430A1 (en) Method and system for photodisruption of tissue of the eye
HK1040184A1 (en) Combination therapy for treating glaucoma
WO1998039293A3 (en) 13-thia prostaglandins for use in glaucoma therapy
AU2001256855A1 (en) Preparation for the prevention and treatment of ocular disorders
MXPA03003741A (en) Methods and compositions for the treatment of diseases of the eye.
ZA200003768B (en) Methods and compositions for treating diseases and conditions of the eye.
AU2001271887A1 (en) Methods for diagnosis and treatment of psychiatric disorders
AU2002246490A1 (en) Method of treating parkinson's disease
AU2003241398A1 (en) Methods of treatment of glaucoma and other conditions mediated by nos-2 expression via inhibition of the egfr pathway
AU4511201A (en) Compositions and methods for the induction and treatment of retinal detachments
WO2002072105A3 (en) Improved prostanoid therapies for the treatment of glaucoma
AU2002227895A1 (en) Sulphonamides for the treatment of central nervous system diseases
AU2001270642A1 (en) Method for the treatment of glaucoma and ocular hypertension by administering nucleotides
AU2002311623A1 (en) Process for the preparation of 1,4-dihydropyridines and novel 1,4-dihydropyridines useful as therapeutic agents
AU4114301A (en) Treatment of ocular hypertension and glaucoma
AU2003215820A1 (en) Method for treating ocular hypertension and glaucoma
AU2001283957A1 (en) Treatment of ocular disorders with somatostatin analogues
AU2002322769A1 (en) Method for treatment of ocular hypertension and glaucoma
AU2002329000A1 (en) Methods for diagnosis and treatment of diseases associated with altered expression of pik3r1
AU2001216038A1 (en) Treatment of glaucoma and ocular hypertension
AU2003216547A1 (en) Compositions and methods for treating glaucoma and ocular hypertension
AU2001236909A1 (en) Method of treating disorders of the eye